The results showed that subpopulations with drug-resistant potential were mainly regulated by TFs such as CRZB5, AR, HLF, and RARA, implying that tracking these genes is helpful for understanding HCC progression. The gene discussed is HLF; the disease is hepatocellular carcinoma.